State-Dependent Impulsive Control Strategies for a Tumor-Immune Model

Rami, F., Mollainezhad, H., & Salehi, M. (2016). Induced Pluripotent Stem Cell as a New Source for Cancer Immunotherapy. Genetics Research International, 2016(), 2-10. https://doi.org/10.1155/2016/3451807
Nicot, C. (2015). Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia. Journal of Oncology, 2015(), 213-223. https://doi.org/10.1155/2015/183590
Sung, H. H., Shen, K. L., & Sytwu, H. K. (2004). Immunomodulation by Decoy Receptor 3: Lessons from Tumors to Therapeutic Approaches. Journal of Medical Sciences, 24(6), 301-306. https://www.airitilibrary.com/Article/Detail?DocID=10114564-200412-201305090003-201305090003-301-306
YAFIA, R. (2006). STABILITY OF LIMIT CYCLE IN A DELAYED MODEL FOR TUMOR IMMUNE SYSTEM COMPETITION WITH NEGATIVE IMMUNE RESPONSE. Discrete Dynamics in Nature and Society, 2006(), 409-421. https://doi.org/10.1155/DDNS/2006/58463
Stansfield, J. C., Rusay, M., Shan, R., Kelton, C., Gaykalova, D. A., Fertig, E. J., Califano, J. A., & Ochs, M. F. (2016). Toward Signaling-Driven Biomarkers Immune to Normal Tissue Contamination. Cancer Informatics, (2016), 15-21. https://doi.org/10.4137/CIN.S32468